Cargando…
Development of plasma ghrelin level as a novel marker for gastric mucosal atrophy after Helicobacter pylori eradication
BACKGROUND AND AIM: The severity of atrophic gastritis is significantly associated with the risk of gastric cancer. Although the current gold standard for assessing the gastric cancer risk is esophagogastroduodenoscopy with a pathological examination, the development of less-invasive biomarkers is w...
Autores principales: | Mori, Hideki, Suzuki, Hidekazu, Matsuzaki, Juntaro, Kameyama, Kaori, Igarashi, Koji, Masaoka, Tatsuhiro, Kanai, Takanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891226/ https://www.ncbi.nlm.nih.gov/pubmed/35000515 http://dx.doi.org/10.1080/07853890.2021.2024875 |
Ejemplares similares
-
Response to letter regarding: development of plasma ghrelin level as a novel marker for gastric mucosal atrophy after Helicobacter pylori eradication
por: Mori, Hideki, et al.
Publicado: (2022) -
Development of plasma ghrelin level as a novel marker for gastric mucosal atrophy after Helicobacter pylori eradication
por: Yang, Hang, et al.
Publicado: (2022) -
Neutrophil-activating Protein Polymorphism of Helicobacter pylori Determines the Host Risk of Dyspepsia
por: Matsuzaki, Juntaro, et al.
Publicado: (2019) -
Effect of polyphenol compounds on Helicobacter pylori eradication: a systematic review with meta-analysis
por: Wang, Qiuxiang, et al.
Publicado: (2023) -
Efficacy and safety of low‐dose rifabutin‐based 7‐day triple therapy as a third‐ or later‐line Helicobacter pylori eradication regimen
por: Inokuchi, Kazumi, et al.
Publicado: (2022)